The Epidermal Growth Factor Receptor (EGFR) is a transmembrane protein involved in vital cellular processes, including proliferation and survival. In many types of cancer, especially those of epithelial origin, abnormalities in EGFR expression or function contribute to tumor development and progression. Targeted therapies aimed at blocking EGFR have become a critical part of the cancer...

  Advanced Non-Small Cell Lung Cancer (NSCLC) treatment strategies are experiencing unprecedented innovation through the development of bispecific antibody therapeutics. These sophisticated molecular constructs represent the next generation of precision oncology, offering dual-targeting capabilities that traditional single-agent therapies cannot match. As researchers continue to advance...